Clough Capital Partners L P bought a new position in Sanofi (NASDAQ:SNY – Free Report) in the third quarter, HoldingsChannel.com reports. The firm bought 274,400 shares of the company’s stock, valued at approximately $14,719,000. Sanofi accounts for 1.6% of Clough Capital Partners L P’s investment portfolio, making the stock its 16th biggest position. Other institutional […]
EPG Wealth Management LLC cut its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 8.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,913 shares of the company’s stock after selling 1,621 shares during the period. EPG Wealth Management LLC’s holdings in […]
Clearstead Advisors LLC trimmed its stake in Sanofi (NASDAQ:SNY – Free Report) by 32.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 565 shares of the company’s stock after selling 275 shares during the quarter. Clearstead Advisors LLC’s holdings in […]
Clearstead Advisors LLC lessened its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 32.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 565 shares of the company’s stock after selling 275 shares during the period. Clearstead Advisors LLC’s […]
Guardian Capital LP cut its stake in Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the third quarter, Holdings Channel.com reports. The fund owned 128,161 shares of the company’s stock after selling 17,386 shares during the quarter. Guardian Capital LP’s holdings in Sanofi were worth $6,875,000 as of its most recent filing with the Securities […]